gate2biotech 2007 international conference brno, 17 october 2007 alice tomášková czechinvest...
Post on 22-Dec-2015
216 views
TRANSCRIPT
GATE2BIOTECH 2007
International conferenceBrno, 17 October 2007
Alice Tomášková
CZECHINVEST
Deputy Chief of Executive
Biotechnology and Pharmacy
High growing sector with great future potential relating to elderly population
Development of infrastructure for biotechnologies - science incubators
Biotechnology and Pharmacy
Cluster activities
Development of bioinformatics
Research and development of new technologies and drugs
National and European Grants
National Programmes (National Innovative Policy) - Program Innovation; Prosperity; Potential; Tandem etc.
Investment incentives - Program for Support of Technology Centres and Business Support services
Structural Funds - Operation programmes Research and Development for Innovation - Operation programme Business and Innovation - Operation programme Education for Competitiveness
EU Grants: - Seventh Research Framework programme - E - Contentplus - Visegrad fund etc.
Biotech and Pharmacy Clusters in the Czech Republic
PRAHA
OSTRAVA
BRNO
AMR AMARANTH
Aveflor
FerringBiotest
Biopharm
Biomedia
DekontaGeneAge Technologies
Generi-Biotech
Clonestar
Favea
Chemopharma
Biovendor
Contipro group
Bioveta
Ardeapharma
Beckman Coulter - Immunotech
Noventis
Infusia
Imunomedica
Farmark
Envisan-Gem
Dyntec
Dr. Bubeníček
HERBACOS-BOFARMA
Pliva - Lachema
Olchemin
Mediplast
Medicom International
Medicol
IVAX PharmaceuticalsBaxterI.Q.A Vidia
Exbio
Lonza Biotech
Role of CzechInvest
Czech Republic has got a long tradition of research development and dispose of giant science potential
ROLE OF CZECHINVEST IS TO BRING TOGETHER CZECH INTELLECTUAL POTENTIAL AND FOREIGN INVESTMENTS
SUPPORTS HIGH ADDED VALUE PROJECTS
CzechInvest, the Investment and Business Development Agency, is an agency of the Ministry of Industry & Trade of the Czech Republic
© Copyright, CzechInvest 2006. All rights reserved
Thank you for your attention
Alice TomáškováCzechInvest Deputy CEOPhone: +420 296 342 584 Fax: +420 296 342 502Email: [email protected]